Malaria

ClinicalJuly 30, 2026

Phase 1 Study of LAI MMV055 and MMV371 in Healthy Participants Initiated

A Phase 1 single ascending dose study is underway to evaluate the safety and pharmacokinetics of LAI MMV055 alone and in combination with MMV371 in healthy participants.

Companies

Assets

Recent signals(5)

Phase 1b Study of Lotilaner Shows Safety and Mosquitocidal Activity in Mali

Safety Evaluation of PfSPZ Vaccine in Pregnant Women in Mali Initiated

Phase 1 Study of LAI MMV055 and MMV371 in Healthy Participants Initiated

Sanaria Inc. Initiates PfSPZ-LARC2 Vaccine Trial for Women in Mali

Study on Malaria Infection Factors in Pregnant Women and Children in Mali

Upcoming catalysts

Indications

Get signals before the market moves